Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 20:26:13 GMT 2025
by
admin
on
Tue Apr 01 20:26:13 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG2/4 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
C3VX249T6L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000175575
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
||
|
NCI_THESAURUS |
C308
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
||
|
FDA ORPHAN DRUG |
513015
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
||
|
FDA ORPHAN DRUG |
783320
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
||
|
FDA ORPHAN DRUG |
606917
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C124657
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
C3VX249T6L
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
10659
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
1803171-55-2
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
100000177402
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
m12119
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
Ravulizumab
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
DE-132
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
5322
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
2107301
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
C3VX249T6L
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
2107316
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
ALTERNATIVE | |||
|
Ravulizumab
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY | |||
|
DB11580
Created by
admin on Tue Apr 01 20:26:13 GMT 2025 , Edited by admin on Tue Apr 01 20:26:13 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_136 | 3_214 |
| 1_149 | 1_205 |
| 1_224 | 2_224 |
| 1_225 | 2_225 |
| 1_228 | 2_228 |
| 1_231 | 2_231 |
| 1_262 | 1_322 |
| 1_368 | 1_426 |
| 2_22 | 2_96 |
| 2_136 | 4_214 |
| 2_149 | 2_205 |
| 2_262 | 2_322 |
| 2_368 | 2_426 |
| 3_23 | 3_88 |
| 3_134 | 3_194 |
| 4_23 | 4_88 |
| 4_134 | 4_194 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_298 |
| N | 2_298 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
INNOVATOR->PARENT |
|
||
|
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | [1_1] [2_1] | PIDOLIC ACID | SZB83O1W42 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|